156 related articles for article (PubMed ID: 11468548)
1. Patterns of engraftment in different strains of immunodeficient mice reconstituted with human peripheral blood lymphocytes.
Berney T; Molano RD; Pileggi A; Cattan P; Li H; Ricordi C; Inverardi L
Transplantation; 2001 Jul; 72(1):133-40. PubMed ID: 11468548
[TBL] [Abstract][Full Text] [Related]
2. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
3. Long term substitution and specific immune responses after transfer of bovine peripheral blood lymphocytes into severe combined immunodeficient mice.
Hölscher C; Hasch G; Joswig N; Stauffer U; Müller U; Mossmann H
Vet Immunol Immunopathol; 1999 Sep; 70(1-2):67-83. PubMed ID: 10507288
[TBL] [Abstract][Full Text] [Related]
4. High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1.
Shpitz B; Chambers CA; Singhal AB; Hozumi N; Fernandes BJ; Roifman CM; Weiner LM; Roder JC; Gallinger S
J Immunol Methods; 1994 Feb; 169(1):1-15. PubMed ID: 7907638
[TBL] [Abstract][Full Text] [Related]
5. Mouse strain and conditioning regimen determine survival and function of human leucocytes in immunodeficient mice.
Tournoy KG; Depraetere S; Pauwels RA; Leroux-Roels GG
Clin Exp Immunol; 2000 Jan; 119(1):231-9. PubMed ID: 10606988
[TBL] [Abstract][Full Text] [Related]
6. Targeting of pancreatic islets of severe combined immunodeficient mice by passive transfer of allogeneic spleen cells from non-obese diabetic mice.
Reddy S; Liu W; Elliott RB
Immunol Cell Biol; 1994 Oct; 72(5):390-7. PubMed ID: 7835983
[TBL] [Abstract][Full Text] [Related]
7. Engraftment of human peripheral blood lymphocytes in normal strains of mice.
Lubin I; Segall H; Marcus H; David M; Kulova L; Steinitz M; Erlich P; Gan J; Reisner Y
Blood; 1994 Apr; 83(8):2368-81. PubMed ID: 8161804
[TBL] [Abstract][Full Text] [Related]
8. Improved engraftment of human spleen cells in NOD/LtSz-scid/scid mice as compared with C.B-17-scid/scid mice.
Greiner DL; Shultz LD; Yates J; Appel MC; Perdrizet G; Hesselton RM; Schweitzer I; Beamer WG; Shultz KL; Pelsue SC
Am J Pathol; 1995 Apr; 146(4):888-902. PubMed ID: 7717456
[TBL] [Abstract][Full Text] [Related]
9. Physiologic human T-cell responses to OKT3 in the human peripheral blood lymphocyte-severe combined immunodeficiency mouse model.
Dessureault S; Shpitz B; Alloo J; Rotstein O; Sandhu J; Hozumi N; Fernandes B; Gallinger S
Transplantation; 1997 Sep; 64(6):811-6. PubMed ID: 9326403
[TBL] [Abstract][Full Text] [Related]
10. NOD/LtSz-Rag1null mice: an immunodeficient and radioresistant model for engraftment of human hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse diabetogenic T cells.
Shultz LD; Lang PA; Christianson SW; Gott B; Lyons B; Umeda S; Leiter E; Hesselton R; Wagar EJ; Leif JH; Kollet O; Lapidot T; Greiner DL
J Immunol; 2000 Mar; 164(5):2496-507. PubMed ID: 10679087
[TBL] [Abstract][Full Text] [Related]
11. High levels of viremia in hu-PBL-NOD-scid mice with HIV-1 infection.
Koyanagi Y; Tanaka Y; Tanaka R; Misawa N; Kawano Y; Tanaka T; Miyasaka M; Ito M; Ueyama Y; Yamamoto N
Leukemia; 1997 Apr; 11 Suppl 3():109-12. PubMed ID: 9209314
[TBL] [Abstract][Full Text] [Related]
12. Immunohistology and immunocytology of human T-cell chimerism and graft-versus-host disease in SCID mice.
Hoffmann-Fezer G; Gall C; Zengerle U; Kranz B; Thierfelder S
Blood; 1993 Jun; 81(12):3440-8. PubMed ID: 8099506
[TBL] [Abstract][Full Text] [Related]
13. CD3+ T cells in severe combined immunodeficiency (SCID) mice. V. Allogeneic T cells engrafted into SCID mice do not induce graft-versus-host disease in spite of the absence of host veto and natural suppressor cell activity.
Tscherning T; Rudolphi A; Reimann J; Claesson MH
Scand J Immunol; 1991 Dec; 34(6):795-801. PubMed ID: 1836277
[TBL] [Abstract][Full Text] [Related]
14. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice.
Christianson SW; Greiner DL; Hesselton RA; Leif JH; Wagar EJ; Schweitzer IB; Rajan TV; Gott B; Roopenian DC; Shultz LD
J Immunol; 1997 Apr; 158(8):3578-86. PubMed ID: 9103418
[TBL] [Abstract][Full Text] [Related]
15. Engraftment of human peripheral blood leukocytes into severe combined immunodeficient mice results in the long term and dynamic production of human xenoreactive antibodies.
Williams SS; Umemoto T; Kida H; Repasky EA; Bankert RB
J Immunol; 1992 Oct; 149(8):2830-6. PubMed ID: 1401915
[TBL] [Abstract][Full Text] [Related]
16. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer.
Blazar BR; Taylor PA; McElmurry R; Tian L; Panoskaltsis-Mortari A; Lam S; Lees C; Waldschmidt T; Vallera DA
Blood; 1998 Nov; 92(10):3949-59. PubMed ID: 9808589
[TBL] [Abstract][Full Text] [Related]
17. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
[TBL] [Abstract][Full Text] [Related]
18. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
19. CD3+ T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic scid mice.
Rudolphi A; Spiess S; Conradt P; Claesson MH; Reimann J
Eur J Immunol; 1991 Jul; 21(7):1591-600. PubMed ID: 1829409
[TBL] [Abstract][Full Text] [Related]
20. Engraftment and humoral immunity in SCID and RAG-2-deficient mice transplanted with human peripheral blood lymphocytes.
Steinsvik TE; Gaarder PI; Aaberge IS; Løvik
Scand J Immunol; 1995 Dec; 42(6):607-16. PubMed ID: 8552984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]